Correlation Between Moadata Co and GeneBioTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moadata Co and GeneBioTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moadata Co and GeneBioTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moadata Co and GeneBioTech Co, you can compare the effects of market volatilities on Moadata Co and GeneBioTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moadata Co with a short position of GeneBioTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moadata Co and GeneBioTech.

Diversification Opportunities for Moadata Co and GeneBioTech

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Moadata and GeneBioTech is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Moadata Co and GeneBioTech Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneBioTech and Moadata Co is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moadata Co are associated (or correlated) with GeneBioTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneBioTech has no effect on the direction of Moadata Co i.e., Moadata Co and GeneBioTech go up and down completely randomly.

Pair Corralation between Moadata Co and GeneBioTech

Assuming the 90 days trading horizon Moadata Co is expected to under-perform the GeneBioTech. In addition to that, Moadata Co is 2.02 times more volatile than GeneBioTech Co. It trades about -0.12 of its total potential returns per unit of risk. GeneBioTech Co is currently generating about -0.09 per unit of volatility. If you would invest  343,500  in GeneBioTech Co on September 23, 2024 and sell it today you would lose (16,500) from holding GeneBioTech Co or give up 4.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Moadata Co  vs.  GeneBioTech Co

 Performance 
       Timeline  
Moadata Co 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moadata Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
GeneBioTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GeneBioTech Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, GeneBioTech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Moadata Co and GeneBioTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moadata Co and GeneBioTech

The main advantage of trading using opposite Moadata Co and GeneBioTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moadata Co position performs unexpectedly, GeneBioTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneBioTech will offset losses from the drop in GeneBioTech's long position.
The idea behind Moadata Co and GeneBioTech Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments